• OPEN AN ACCOUNT
Indian Indices
Sensex
75,656.63 -476.18
( -0.63%)
Global Indices
Nasdaq
53,435.25 -271.85
(-0.51%)
Dow Jones
7,739.60 -29.11
(-0.37%)
Hang Seng
65,678.73 -721.11
(-1.09%)
Nikkei 225
10,817.95 -13.14
(-0.12%)
Forex
USD-INR
94.44 -0.05
(-0.05%)
EUR-INR
109.67 -0.05
(-0.04%)
GBP-INR
127.62 -0.01
(-0.01%)
JPY-INR
0.60 0.00
(0.12%)

EQUITY - MARKET SCREENER

Alkem Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
539523
INE540L01014
1170.8077615
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ALKEM
27.63
61934.67
EPS(TTM)
Face Value()
Div & Yield %
187.45
2
1.02
 

Tata Chemicals reports consolidated net loss of Rs 2132.00 crore in the March 2026 quarter
May 05,2026
Net Loss of Tata Chemicals reported to Rs 2132.00 crore in the quarter ended March 2026 as against net loss of Rs 56.00 crore during the previous quarter ended March 2025. Sales declined 2.02% to Rs 3438.00 crore in the quarter ended March 2026 as against Rs 3509.00 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 1896.00 crore in the year ended March 2026 as against net profit of Rs 235.00 crore during the previous year ended March 2025. Sales declined 2.04% to Rs 14584.00 crore in the year ended March 2026 as against Rs 14887.00 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales3438.003509.00 -2 14584.0014887.00 -2
OPM %7.979.32 -12.3813.12 -
PBDT198.00256.00 -23 1698.001769.00 -4
PBT-145.00-37.00 -292 497.00646.00 -23
NP-2132.00-56.00 -3707 -1896.00235.00 PL